Navigation Links
Alseres Pharmaceuticals, Inc. Complies with NASDAQ Rule Regarding Recently Filed 10-K
Date:3/31/2009

HOPKINTON, Mass., March 31 /PRNewswire-FirstCall/ -- Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE) today announced that the report of the Company's independent registered public accounting firm regarding the Company's 2008 financial statements contained an explanatory paragraph regarding the Company's ability to continue as a going concern. NASDAQ Marketplace Rules require NASDAQ-traded companies to publicly announce if their Annual Report on Form 10-K includes an audit report containing a going concern explanatory paragraph. For further information, please refer to the Company's Annual Report on Form 10-K filed on March 31, 2009.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080813/NEW056LOGO )

About Alseres Pharmaceuticals, Inc.

Alseres Pharmaceuticals, Inc. (ALSE) is engaged in the development of therapeutic and diagnostic products primarily for disorders in the central nervous system (CNS). The Company maintains a world-class intellectual property position in the field of regenerative therapeutics. The Company's energy and focus is reflected in several important initiatives. Cethrin, a recombinant-protein-based drug designed to promote nerve repair after acute spinal cord injury, demonstrated positive interim results in a Phase I/IIa clinical trial. The Company's research and pre-clinical programs include, Inosine for the treatment of spinal cord injury and stroke, Oncomodulin for the treatment of ocular injury and disease and research programs directed at a number of regenerative therapies including bone repair. The Company has a robust molecular imaging development program targeting diagnosis of Parkinson's disease and potent
'/>"/>

SOURCE Alseres Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Alseres Pharmaceuticals, Inc. Announces $1 Million Financing
2. Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results
3. Alseres Pharmaceuticals, Inc. Raises $5 Million
4. Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights
5. Alseres Pharmaceuticals to Host 2007 Financial Results Conference Call
6. Alseres Pharmaceuticals Presents Inosine and Dopamine Transporter (DAT) Blocker Preclinical Data at the American Society for Experimental NeuroTherapeutics (ASENT) Conference
7. Alseres Pharmaceuticals, Inc. to Present at Windhovers Therapeutic Area Partnerships Conference
8. Alseres Pharmaceuticals, Inc. to Present at Bio Investor Forum 2007 Annual Meeting
9. Angiotech Pharmaceuticals, Inc. announces License Agreement with Baxter International Inc.
10. Trubion Pharmaceuticals, Inc. Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Systemic Lupus Erythematosus (SLE)
11. ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...able in German . , Whether it,s CD packagin...Radio Frequency Identification) are increasingly f...possible to label objects or goods and identify th...te scanner can read and process the data contained...s under production conditions of up to 100 degrees...
(Date:11/24/2009)...,Nov.24/PRNewswire/--Twomoreprestigiousuniversitie...ejobboardandcareerssiteforlifescienceprofessionals...bersofthejobboard,joining28othermajorlifesciencetr...ercenter.com ,isonlyforpost-graduatesinthelifescie...ontheInternet,BioCareerCenteristheonlyonethatserve...
(Date:11/24/2009)... Health care employment grew by 29,000 jobs in ...w consistent growth during the U.S. recession. How...ouble, and health systems are coming closer to hav...just administrators. , (V...continued growing in October despite the shedding ...
(Date:11/24/2009)...PRNewswire-Asia/--ShanghaiBiolaxyannouncedthe,Chin...edthe,investigationalnewdrugapplication(IND)forits...mulationtotreatdiabetes.ThisIND,approvalallowsBiol...iabetesisadisordercharacteristicofhighbloodglucose...resultinseveremicro-and,macro-vasculardiseases,los...
Breaking Biology Technology:Intelligence inside metal components 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2
...ds Product Portoflio with Third FDA Market Clearan..., WAYNE, Pa., Jan. 29 Escalon Medical Corp.,(Nas...510(k) clearance from,the U.S. Food and Drug Admin... Ultrasound System for use with assisted vascular ...nc., plans to commence shipments of,the product in...
...., Jan. 29 Edwards Lifesciences,Corporation (NYSE...ies to,treat advanced cardiovascular disease, plan...r ended December 31, 2007 after the market closes ...rence call at 5:00 p.m. ET,that day to discuss its... dial (877) 407-8037 or (201),689-8037. For 72 hou...
...cement of Convertible Preferred Stock -, DALLAS, ...n Board: ACCP) announced today that it has execute...ompany has entered into agreements,with institutio...ate of,$2.7 million in gross proceeds of the Compa...uity is in addition to the $9.5 million in gross,p...
Other Biology Technology:Escalon(R) Announces FDA 510(K) Clearance for VascuView(TM) Visual Ultrasound System For Assisted Vascular Access 2Escalon(R) Announces FDA 510(K) Clearance for VascuView(TM) Visual Ultrasound System For Assisted Vascular Access 3Escalon(R) Announces FDA 510(K) Clearance for VascuView(TM) Visual Ultrasound System For Assisted Vascular Access 4Edwards Lifesciences to Host Earnings Conference Call on February 5, 2008 2Access Pharmaceuticals Announces $2.7 Million New Equity 2Access Pharmaceuticals Announces $2.7 Million New Equity 3
(Date:11/23/2009)... day matters to forest trees dealing with drought,...eam led by Professor Malcolm Campbell, University ...ch and colleagues in the department of cell and sy...talizing on their previous work to decode the geno...how poplar trees use their 45,000 genes to respond...
(Date:11/23/2009)...ts gathered this week for the seventh annual Natio...This year,s topic, "Synthetic Biology," brought to...ers to explore the engineering, scientific, and so...hetic biology. , Bonnie L. Bassler, professor of...s year,s conference chair, challenged the attendee...
(Date:11/23/2009)...ncontrovertible evidence" that the volcanic super-...,000 years ago deforested much of central India, s...port. , The volcano ejected an estimated 800 cub...a crater (now the world,s largest volcanic lake) t... Ash from the event has been found in India, the I...
Breaking Biology News(10 mins):Time of day matters to thirsty trees, U of T researcher discovers 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Association of Gaming Equipment Manufacturers 28AGEM 29 Announces 24100 000 in Contributions to Organizations Working to Assist Problem Gamblers 52789 1Association of Gaming Equipment Manufacturers 28AGEM 29 Announces 24100 000 in Contributions to Organizations Working to Assist Problem Gamblers 52789 2Association of Gaming Equipment Manufacturers 28AGEM 29 Announces 24100 000 in Contributions to Organizations Working to Assist Problem Gamblers 52789 3NASA Extends Bioastronautics Contract With Wyle for Total Value of 24976 Million 13210 1NASA Extends Bioastronautics Contract With Wyle for Total Value of 24976 Million 13210 2Brookdale Announces Second Quarter 2009 Release and Earnings Call 52783 1
...em with antibiotics is that, eventually, bacteria ...ng the gene that confers such resistance, a new dr... University scientists tested the new drug, called...ns of multidrug-resistant Staphylococcus aureus (M... majority of staphylococcal infections worldwide, ...
...N, R.I. July 2, 2008 Standing in a greenhouse at... smiling even though it appeared that something ha...es of grass she planted last February in hundreds ...or of turf science wasn,t surprised. That,s becau...er water for five months, and few varieties of gra...
...ch findings published online in The FASEB Journal... what we eat, our intelligence can improve. Accord...a wide range of foods from infant formula to eggs ...ities. , "I hope human brains will, like those of...atment by making more brain synapses and thus rest...
Other Biology News:New antibiotic beats superbugs at their own game 2Search for salt tolerant grasses aims to improve roadside plantings 2
Mouse Anti-MMP-20 Monoclonal Antibody, Unconjugated, Clone MMP2/2C1 from ABR-Affinity BioReagents
Rabbit Anti-T-box 6 Monoclonal Antibody, Unconjugated, Clone PADZMD.501 from Invitrogen
RSK2 siRNA siAb™ Assay Kit from Upstate
TriContinentMultiWash III from Femto Scientific
Biology Products: